Updates and Pearls from the Society of Pediatric Dermatology Meeting

Authors

  • Cathryn Sibbald, MD, MSc, FRCPC Cross Appointment, Division of Dermatology, Department of Medicine, University of Toronto, Department of Paediatrics, Faculty of Medicine, University of Toronto

DOI:

https://doi.org/10.58931/cdt.2024.53124

Abstract

The 49th annual Society of Pediatric Dermatology (SPD) meeting was a tremendous success, attracting over 650 attendees, the highest number ever recorded. The 3-day conference featured a wide range of new developments and tips and tricks from experts in the field.  

Author Biography

Cathryn Sibbald, MD, MSc, FRCPC, Cross Appointment, Division of Dermatology, Department of Medicine, University of Toronto, Department of Paediatrics, Faculty of Medicine, University of Toronto

Dr. Cathryn Sibbald is a dermatologist who completed her residency training at the University of Toronto and is board certified in Canada and the US. She completed fellowship training in pediatric dermatology at the Children’s Hospital of Philadelphia.  She has an MSc in Epidemiology from the London School of Hygiene & Tropical Medicine and a BSc Ph.M. from the University of Toronto. She is a staff physician with research and clinical activities at the Hospital for Sick Children, and recently joined the pyoderma gangrenosum clinic at Women’s College Hospital. She is an assistant Professor at the University of Toronto in the Department of Pediatrics with a cross appointment to the Department of Medicine. Her clinical interests are broad and include alopecia, morphea, and laser treatment of vascular lesions.

References

Metry D, Copp HL, Rialon KL, Iacobas I, Baselga E, Dobyns WB, et al. Delphi Consensus on diagnostic criteria for LUMBAR syndrome. J Pediatr. 2024;272:114101. doi:10.1016/j.jpeds.2024.114101

Swonke ML, Smith SA, Ohlstein JF, Siddiqui F, Szeremeta W, Pine HS. Unexplained destructive nasal lesions in half-brothers: a possible case of Munchausen syndrome by proxy. Int J Pediatr Otorhinolaryngol. 2019;123:75-78. doi:10.1016/j.ijporl.2019.04.029

Kellogg ND, Farst KJ, Adams JA. Interpretation of medical findings in suspected child sexual abuse: an update for 2023. Child Abuse Negl. 2023;145:106283. doi:10.1016/j.chiabu.2023.106283

Kostopoulou E, Anagnostis P, Bosdou JK, Spiliotis BE, Goulis DG. Polycystic ovary syndrome in adolescents: pitfalls in diagnosis and management. Curr Obes Rep. 2020;9(3):193-203. doi:10.1007/s13679-020-00388-9

Bhatti S, Hussain S, Zaenglein A. Safety of sprionolactone use in children and adolescents: a systematic review. The 8th Annual Pediatric Dermatology Research Alliance (PeDRA) Meeting; October 22-23, 2020; Virtual2020.

Powell A. Choosing the right oral contraceptive pill for teens. Pediatr Clin North Am. 2017;64(2):343-358. doi:10.1016/j.pcl.2016.11.005

Pope E, Lara-Corrales I, Sibbald C, Liy-Wong C, Kanigsberg N, Drolet B, et al. Noninferiority and safety of nadolol vs propranolol in infants with infantile hemangioma: a randomized clinical trial. JAMA Pediatr. 2022;176(1):34-41. doi:10.1001/jamapediatrics.2021.4565

Roerdink EM, Flokstra-de Blok BM, Blok JL, Schuttelaar ML, Niggemann B, Werfel T, et al. Association of food allergy and atopic dermatitis exacerbations. Ann Allergy Asthma Immunol. 2016;116(4):334-338. doi:10.1016/j.anai.2016.01.022

Renert-Yuval Y, Ezzedine K, Grimes P, Rosmarin D, Eichenfield LF, Castelo-Soccio L, et al. Expert recommendations on use of topical therapeutics for vitiligo in pediatric, adolescent, and young adult patients. JAMA Dermatol. 2024;160(4):453-461. doi:10.1001/jamadermatol.2024.0021

Herskovitz I, Miteva M. Central centrifugal cicatricial alopecia: challenges and solutions. Clin Cosmet Investig Dermatol. 2016;9:175-181. doi:10.2147/ccid.S100816

Guo YX, Wang HX, Wang SS, Croitoru D, Piguet V, Gao XH, et al. Treatment with selumetinib for Café-au-Lait macules and plexiform neurofibroma in pediatric patients with Neurofibromatosis Type 1. JAMA Dermatol. 2024;160(3):366-368. doi:10.1001/jamadermatol.2023.5338

Borgia P, Piccolo G, Santangelo A, Chelleri C, Viglizzo G, Occella C, et al. Dermatologic effects of selumetinib in pediatric patients with Neurofibromatosis Type 1: clinical challenges and therapeutic management. J Clin Med. 2024;13(6). doi:10.3390/jcm13061792

Haller CN, Leszczynska MA, Brichta L, Maier E, Riddington IM, Choate KA, et al. Topical trametinib for epidermal and sebaceous nevi in a child with Schimmelpenning-Feuerstein-Mims syndrome. Pediatr Dermatol. 2024;41(3):523-525. doi:10.1111/pde.15523

Lieberman JA, Chu DK, Ahmed T, Dribin TE, Abrams EM, Anagnostou A, et al. A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: a position paper of the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 2024. doi:10.1016/j.anai.2024.05.014

Eickstaedt JB, Starke S, Krakora D, Hinshaw M, Arkin LM. Clearance of pediatric actinic prurigo with dupilumab. Pediatr Dermatol. 2020;37(6):1176-1178. doi:10.1111/pde.14311

Netravali IA, Sockler PG, Heimall J, Treat JR. Rapid resolution of diffuse warts following initiation of dupilumab for severe atopic dermatitis. Pediatr Dermatol. 2024;41(2):275-278. doi:10.1111/pde.15414

Rodriguez-Lago L, Borrego L. Norwegian Scabies in an atopic patient under dupilumab treatment. Dermatitis. 2022;33(5):e54-e55. doi:10.1097/der.0000000000000926

Krakowski AC, Senft SC, Heymann WR. Demodex Folliculitis and recent dupilumab administration. Pediatrics. 2021;147(5). doi:10.1542/peds.2020-029520

Siegfried EC, Arkin LM, Chiu YE, Hebert AA, Callen JP, Castelo-Soccio L, et al. Methotrexate for inflammatory skin disease in pediatric patients: consensus treatment guidelines. Pediatr Dermatol. 2023;40(5):789-808. doi:10.1111/pde.15327

CenterWatch. FDA Approved Drugs. Princeton, NJ: WCG Company; 2024 [Accessed 28 July 2024] Available from: https://www.centerwatch.com/directories/1067-fda-approved-drugs.

Downloads

Published

2024-10-02

How to Cite

1.
Sibbald C. Updates and Pearls from the Society of Pediatric Dermatology Meeting. Can Dermatol Today [Internet]. 2024 Oct. 2 [cited 2024 Nov. 21];5(3):11–16. Available from: https://canadiandermatologytoday.com/article/view/5-3-Sibbald

Issue

Volume 5, Issue 3, Fall 2024

Section

Articles